Corporate News tagged:
Stem Cells (3)
Jun 30, 2015
Stemgent, a REPROCELL Group Company Announces a New High Performance Self-replicative RNA Reprogramming Kit
Read REPROCELL Group company Stemgent inc.'s announcement of a New High Performance Self-replicative RNA Reprogramming Kit: Stemgent StemRNA™-SR
Jun 04, 2015
REPROCELL Concludes the License Agreement with Keio University for the Exclusive Sale of Disease (Hypertrophic Cardiomyopathy) Type Myocardial Cells Derived from iPS Cells
Read about REPROCELLS exclusive distribution and licensing agreement with Keio University regarding myocardial cells originating from disease type iPS Cells
Sep 09, 2014
REPROCELL Acquires the iPS Cell Business Unit of Stemgent, Inc. (USA)
REPROCELL announced that it will acquire the iPS Cell Business Unit of Stemgent, Inc. allowing REPROCELL to expand the product lineup of its iPSC Business